Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-000992

SVP, Chief Technical Officer gave up 4,289 shares (to pay taxes)

  • SVP, Chief Technical Officer acquired 11,559 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-03 Exercise or conversion : show line 1 in the form +11,559 165,782 D
2020-02-03 Shares withheld for taxes : show line 2 in the form −4,289 $19.21 $82,392 161,493 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2020-02-03 Exercise or conversion : show line 3 in the form Common Stock +11,559 $0.00 11,559 0 D
Loading xslF345X03/edgar.xml…